MEI Pharma Inc - Board of Directors Unanimously Agreed on a Strategic Plan to Leverage Recent Positive Voruciclib and Me-344 Clinical Data
MEI Pharma Inc-董事會一致同意一項戰略計劃,以利用最近積極的Voruciclib和Me-344臨床數據
MEI Pharma Inc - Board of Directors Unanimously Agreed on a Strategic Plan to Leverage Recent Positive Voruciclib and Me-344 Clinical Data
MEI Pharma Inc-董事會一致同意一項戰略計劃,以利用最近積極的Voruciclib和Me-344臨床數據
使用瀏覽器的分享功能,分享給你的好友吧